Yogurt drink fortified with menaquinone-7 improves Vitamin K status in a healthy population

Journal of Nutritional Science

Volumn 4, Issue , 2015, Pages

  Knapen, Marjo H J ^a   Braam, Lavienja A J L M ^a   Teunissen, Kirsten J ^a   Zwijsen, Renate M L ^b   Theuwissen, Elke ^a   Vermeer, Cees ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b FRIESLANDCAMPINA   (Netherlands)

Author keywords

Food fortification; n 3 PUFA; Vascular health; Vitamin K status

Indexed keywords

ASCORBIC ACID; C REACTIVE PROTEIN; CALCIUM; CHOLESTEROL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MAGNESIUM; MENAQUINONE 7; OMEGA 3 FATTY ACID; OSTEOCALCIN; SECRETORY PHOSPHOLIPASE A2; SERUM AMYLOID A; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VITAMIN D; VITAMIN K GROUP; VON WILLEBRAND FACTOR; YOGHURT;

ADULT; ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; FOOD INTAKE; FORTIFIED FOOD; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; LIPID METABOLISM; MALE; MIDDLE AGED; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 84994589348     PISSN: 20486790     EISSN: None     Source Type: Journal    
DOI: 10.1017/jns.2015.25     Document Type: Article

References (50)

1. Geleijnse JM, Vermeer C, Grobbee DE, et al. (2004) Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr 134, 3100-3105.
2. Beulens JW, Bots ML, Atsma F, et al. (2009) High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis 203, 489-493.
3. Gast GC, de Roos NM, Sluijs I, et al. (2009) A high menaquinone intake reduces the incidence of coronary heart disease. Nutr Metab Cardiovasc Dis 19, 504-510.
4. Vermeer C (1990) γ-Carboxyglutamate-containing proteins and the Vitamin K-dependent carboxylase. Biochem J 266, 625-636.
5. Suttie JW (1993) Synthesis of Vitamin K-dependent proteins. FASEB J 7, 445-452.
6. Furie B, Bouchard BA & Furie BC (1999) Vitamin K-dependent biosynthesis of γ-carboxyglutamic acid. Blood 93, 1798-1808.
7. Theuwissen E, Cranenburg EC, Knapen MH, et al. (2012) Lowdose menaquinone-7 supplementation improved extra-hepatic Vitamin K status, but had no effect on thrombin generation in healthy subjects. Br J Nutr 108, 1652-1657.
8. Shea MK, O'Donnell CJ, Vermeer C, et al. (2011) Circulating uncarboxylated matrix Gla-protein is associated with Vitamin K nutritional status, but not coronary artery calcium, in older adults. J Nutr 141, 1529-1534.
9. Brugè F, Bacchetti T, Principi F, et al. (2011) Olive oil supplemented with menaquinone-7 significantly affects osteocalcin carboxylation. Br J Nutr 106, 1056-1062.
10. Dalmeijer GW, van der Schouw YT, Magdeleyns E, et al. (2012) The effect of menaquinone-7 supplementation on circulating species of matrix Gla-protein. Atherosclerosis 225, 397-402.
11. Szulc P, Chapuy MC, Meunier PJ, et al. (1996) Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 9, 1769-1774.
12. Szulc P, Arlot M, Chapuy MC, et al. (1994) Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J Bone Miner Res 9, 1591-1595.
13. Booth SL, Broe KE, Peterson JW, et al. (2004) Associations between Vitamin K biochemical measures and bone mineral density in men and women. J Clin Endocrinol Metab 89, 4904-4909.
14. Vergnaud P, Garnero P, Meunier PJ, et al. (1997) Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS study. J Clin Endocrinol Metab 82, 719-724.
15. Knapen MHJ, Nieuwenhuijzen Kruseman AC, Wouters RSME, et al. (1998) Correlation of serum osteocalcin fractions with bone mineral density in women during the first 10 years after menopause. Calc Tissue Int 63, 375-379.
16. Luukinen H, Käkönen SM, Pettersson K, et al. (2000) Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin. J Bone Miner Res 15, 2473-2478.
17. Cranenburg EC, Vermeer C, Koos R, et al. (2008) The circulating inactive form of matrix Gla protein (ucMGP) as a biomarker for cardiovascular calcification. J Vasc Res 45, 427-436.
18. Cranenburg EC, Koos R, Schurgers LJ, et al. (2010) Characterisation and potential diagnostic value of circulating matrix Gla protein (MGP) species. Thromb Haemost 104, 811-822.
19. Rennenberg RJ, de Leeuw PW, Kessels AG, et al. (2010) Calcium scores and matrix Gla-protein levels: association with Vitamin K status. Eur J Clin Invest 40, 344-349.
20. Ueland T, Dahl CP, Gullestad L, et al. (2011) Circulating levels of non-phosphorylated undercarboxylated matrix Gla-protein are associated with disease severity in patients with chronic heart failure. Clin Sci 121, 119-127.
21. Sokoll LJ, Booth SL, O'Brien ME, et al. (1997) Changes in serum osteocalcin, plasma phylloquinone, and urinary γ-carboxyglutamic acid in response to altered intakes of dietary phylloquinone in human subjects. Am J Clin Nutr 65, 779-784.
22. Booth SL, O'Brien-Morse ME, Dallal GE, et al. (1999) Response of Vitamin K status to different intakes and sources of phylloquinonerich foods: comparison of younger and older adults. Am J Clin Nutr 70, 368-377.
23. 2 supplementation on functional Vitamin K deficiency in hemodialysis patients: a randomized trial. Am J Kidney Dis 59, 186-195.
24. 1 (phylloquinone) content of foods: a provisional table. J Food Comp Anal 6, 109-120.
25. Shearer MJ & Bolton-Smith C (2000) The U.K. food data-base for Vitamin K and why we need it. Food Chem 68, 213-218.
26. Schurgers LJ & Vermeer C (2000) Determination of phylloquinone and menaquinones in food. Effect of food matrix on circulating Vitamin K concentrations. Haemostasis 30, 298-307.
27. Gaucheron F (2011) Milk and dairy products: a unique micronutrient combination. J Am Coll Nutr 30, 400S-409S.
28. Kromhout D, Bosschieter EB & de Coulander CL (1987) The inverse relation between fish consumption and 2-year mortality from coronary heart disease. Lancet i, 177-183.
29. Burr ML, Fehily AM, Gilbert JF, et al. (1989) Effects of changes in fat, fish and fibre intakes on death and myocardial reinfarction. Lancet ii, 757-761.
30. Kris-Etherton PM, Harris WS & Appel LJ (2003) Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Arterioscler Thromb Vasc Biol 23, 151-152.
31. Friedewald WT, Levy RI & Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18, 499-502.
32. 2): the Postmenopausal Health Study II. Calc Tissue Int 90, 251-262.
33. 1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age. Calc Tissue Int 73, 21-26.
34. 3 plus calcium on the bone health of older women. J Bone Miner Res 22, 509-519.
35. Booth SL, Dallal G, Shea MK, et al. (2008) Effect of Vitamin K supplementation on bone loss in elderly men and women. J Clin Endocrinol Metab 93, 1217-1223.
36. 2 supplementation does not influence bone loss in early menopausal women: a randomised double-blind placebo-controlled trial. Osteoporos Int 21, 1731-1740.
37. 2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women. Osteoporos Int 18, 963-972.
38. Bugel S, Sorensen AD, Hels O, et al. (2007) Effect of phylloquinone supplementation on biochemical markers of Vitamin K status and bone turnover in postmenopausal women. Br J Nutr 97, 373-380.
39. Cheung AM, Tile L, Lee Y, et al. (2008) Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial. PLoS Med 5, e196.
40. Binkley N, Harke J, Krueger D, et al. (2009) Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone turnover, density, or geometry in healthy postmenopausal North American women. J Bone Miner Res 24, 983-991.
41. 2) supplementation on osteocalcin carboxylation in healthy prepubertal children. Br J Nutr 102, 1171-1178.
42. 1 and natto-derived menaquinone-7. Blood 109, 3279-3283.
43. Shearer MJ, Fu X & Booth SL (2012) Vitamin K nutrition, metabolism, and requirements: current concepts and future research. Adv Nutr 3, 182-195.
44. Shea MK, Dallal GE, Dawson-Hughes B, et al. (2008) Vitamin K, circulating cytokines, and bone mineral density in older men and women. Am J Clin Nutr 88, 356-363.
45. Shea MK, Booth SL, Massaro JM, et al. (2008) Vitamin K and Vitamin D status: associations with inflammatory markers in the Framingham Offspring Study. Am J Epidemiol 167, 313-320.
46. Juanola-Falgarona M, Salas-Salvadó J, Estruch R, et al. (2013) Association between dietary phylloquinone intake and peripheral metabolic risk markers related to insulin resistance and diabetes in elderly subjects at high cardiovascular risk. Cardiovasc Diabetol 12, 7.
47. 2 administration is associated with decreased disease activity in patients with rheumatoid arthritis. Mod Rheumatol 23, 1001-1007.
48. Rangel-Huerta OD, Aguilera CM, Mesa MD, et al. (2012) Omega-3 long-chain polyunsaturated fatty acids supplementation on inflammatory biomarkers: a systematic review of randomized clinical trials. Br J Nutr 107, S159-S170.
49. Yusof HM, Miles E & Calder P (2008) Influence of very long-chain n-3 fatty acids on plasma markers of inflammation in middle-aged men. Prostaglandins Leukot Essent Fatty Acids 78, 219-228.
50. Thies F, Miles E, Nebe-von-Caron G, et al. (2001) Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults. Lipids 36, 1186-1193.